BEUDAMED
    FDA Adverse Event Injury Summary report: N

    FLOSEAL MATRIX HEMOSTATIC SEALANT

    MDR report key: 399870 · Received June 17, 2002

    Report

    Report Number
    2954761-2002-00008
    Event Type
    Injury
    Date Received
    June 17, 2002
    Date of Event
    May 8, 2002
    Report Date
    May 14, 2002
    Manufacturer
    FUSION MEDICAL TECHNOLOGIES, INC.
    Product Code
    LMF
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    TX, US
    Reporter Occupation
    PHYSICIAN

    Narratives

    Description of Event or Problem · 1

    THE PT UNDERWENT A TOTAL THYROIDECTOMY IN 2002. FOLLOWING SURGERY, THE PT DEVELOPED A HEMATOMA IN THE THYROID BED, WHICH REQUIRED MEDICAL NTERVENTION TO EVACUATE. FLOSEAL WAS USED TO ACHIEVE HEMOSTASIS DURING THE INITIAL THYROIDECTOMY PROCEDURE. WHEN THE HEMATOMA WAS EVACUATED, THE SERGEON NOTED THAT THE DRAIN PLACED IN THE PT HAD BEEN BLOCKED BY FLOSEAL GRANULES. FOLLOWING INTERVENTION TO EVACUATE THE HEMATOMA, THE PT RECOVERED WITH NO LONG-TERM ADVERSE EFFECTS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 FLOSEAL MATRIX HEMOSTATIC SEALANT STERILE HEMOSTATIC KIT LMF FUSION MEDICAL TECHNOLOGIES, INC. NA UNK

    Patients

    Seq Age Sex Outcome Treatment
    1 43 YR Required Intervention NONE REPORTED.